Oncology | Absolute Q
Pushing the limit of cancer detection
Applications for digital PCR in oncology are myriad, from biomarker discovery to early detection, liquid biopsy research as well as monitoring recurrence and response to treatment. For all applications in translational cancer research, Absolute Q brings 4-color multiplexing capabilities, improved sensitivity, and a one-step, walkaway workflow to your application.
Rare target quantification in liquid biopsy
Identifying oncogenic mutations via liquid biopsy can be used for early detection, surveillance, measure therapeutic response, residual disease, and emerging resistance to targeted therapies. Here, we demonstrate robust detection of 5 different hotspot mutations down to 0.1% allelic frequency. See the TaqMan™ protocol here.